A detailed history of Pom Investment Strategies, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Pom Investment Strategies, LLC holds 2,000 shares of EOLS stock, worth $21,780. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$21,780
Previous $21.7 Million 49.31%
% of portfolio
0.03%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.99 - $14.91 $19,980 - $29,820
2,000 New
2,000 $28 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $611M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Pom Investment Strategies, LLC Portfolio

Follow Pom Investment Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pom Investment Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pom Investment Strategies, LLC with notifications on news.